商品信息
联系客服
郑重提醒:
无质量问题不接受退换货,下单前请仔细核对信息。
下单后请及时联系客服核对商品价格,订单生效后再付款。
GenWay/Anti IA2/GWB-521228/1x96 Assays
免费咨询热线
4000-520-616
Description:
| Introduction | Type1diabetes,alsoknownasinsulin-dependentdiabetesmellitus(IDDM),resultsfromachronicautoimmunedestructionoftheinsulin-secretingpancreaticbetacells,probablyinitiatedbyexposureofgeneticallysusceptIBLehosttoanenvironmentalagent.Autoimmunedestructionofbetacellsisthoughttobecompletelyasymptomaticuntil80-90%ofthecellsarelost.Thisprocessmaytakeyearstocompleteandmayoccuratanytime.Duringthepreclinicalphase,thisautoimmuneprocessismarkedbycirculatingautoantibodiestobetacellantigens.Theseautoantibodiesarepresentyearsbeforetheonsetoftype1diabetesandpriortoclinicalsymptoms.Earlystudiesutilizedtheimmunofluorescencetestforislet-cellantibodies(ICA),whichhasbeendifficulttostandardizeandisnowreplacedbyacombinationofseveralrADIoimmunoassaysforantibodiesagainstspecificbetacellantigens,suchasinsulin(IAA),glutamicaciddecarboxylase(GAD)andtyrosinephosphataseICA512(IA2).IA2,amemberoftheproteintyrosinephosphatasesfamilyislocalizedinthedensegranulesofpancreaticbetacellsandtheseconddefinedrecombinantisletcellantigen.IA2sharessequenceidentitywiththeisletcellantigen512.ThehigherfrequencyofantibodiestoIA2isexplainedbythepresenceofautoantibodiesdirectedtotheCOOHterminusofIA2whichislackingintheICA512molecule.IA2autoantibodiesarepresentinthemajorityofindividualswithnew-onsettype1diabetesandinindividualsinthepre-diabeticphaseofthedisease.TheappearanceofautoantibodiestoIA2seemstobecorrelatedwiththerapidprogressiontooverttype1diabetes.ThecombinationoftestsforGAD65andIA2autoantibodiesishighlyrelevantforriskassessmentoftype1diabetesinchildrenandadolescence.ThescreeningforGAD65andIA2autoantibodiesdetectmorethan90%ofsubjectsatriskfortype1diabetesandmay,therefore,possessthepotentialtoreplaceICAtechnique. |
|---|---|
| IntendedUse | Anti-IA2kitisanenzymeimmunoassayforthequantitativedeterminationofautoantibodiestoProteinTyrosinePhosphatase(IA2Abs)inhumanserumorplasma.AntiIA2kitisintendedforlaboratoryuseonly. |
| PrincipleoftheAssay | TheassaysystemusestheABIlityofIA2AbsactingdivalentlyandformingabridgebetweenimmobilizedIA2andliquid-phaseIA2-Biotin.InthefirststepIA2AbfromthesamplebindtoIA2coatedonthemicrotiterplate.InasecondstepIA2-Biotinbindstothiscomplex.TheboundIA2-BiotincorrelateswiththeamountofIA2Absinpatient’sSerumorplasma.UnboundIA2-Biotinisremovedbywashing.TheboundIA2-BiotincouldbequantifiedbyadditionofStreptavidin-peroxidaseandachromogenicsubstrate(TMB)andreadingtheopticaldensity(OD)at450nm. |
AdditionalInformation:
| Name | AntiIA2 |
|---|---|
| RelatedProductNames | Anti-tyrosinephosphataseICA512(IA2)ELISAKit,AntityrosinephosphataseICA512ELISA,InsulinAntibodies(IAA)ELISA,AntiInsulinAntibodyELISAKit,AntiIAAELISAKit,AntiIA2ELISA,DiabetesAssay |
| MolecularWeight | 0.5 |
| Concentration | LotSpecific |
| Applications | EnzymeimmunoassayforthequantitativedeterminationofIA2inhumanserumorplasma |
| Reactivity | Human |
| IntendedUse | ResearchUseOnly |

